A Randomized, Double-blind, Multicenter, Parallel-group, Phase IIIb 52 Week Study Evaluating the Efficacy and Safety of PT027 Compared with PT007 Administered As Needed in Participants 12 to < 18 Years of Age with Asthma (ACADIA)

Objective

Clinical Trial Details>>

Principal Investigator(s)
Mirtha Giuliana Gayoso Liviac, MD

Clinical Trial Categories

  • Pediatrics
  • Pulmonology
Sponsor(s)
AstraZeneca
Contact
Avera Research Institute at 605-504-3154
or ARI@Avera.org

Location

  • Avera Research Institute — Sioux Falls
    6001 S Sharon Ave
    Sioux Falls, SD 57108
    Main: 605-504-3154